Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Merck to buy cancer drug developer VelosBio for $2.75 bln

11/05/2020 | 06:35am EDT

Nov 5 (Reuters) - Merck & Co Inc said on Thursday it had agreed to acquire privately held VelosBio for $2.75 billion in cash to expand its cancer pipeline. (Reporting by Ankur Banerjee in Bengaluru; Editing by Sriraj Kalluvila)


ę Reuters 2020
Latest news "Economy & Forex"
05:55pExxon, union try new approach to resolve increasingly bitter dispute
RE
05:39pFitch raises UK outlook on economic resilience to pandemic shock
RE
05:36pUtilities Down Sharply On Treasury Yield Increase Fears -- Utilities Roundup
DJ
05:34pEuro Lost 2.04% to $1.1864 -- Data Talk
DJ
05:34pSterling Lost 2.15% to $1.3803 -- Data Talk
DJ
05:34pDollar Gains 0.50% to 110.23 Yen -- Data Talk
DJ
05:33pCommunications Services Down Amid Growth Bias -- Communications Services Roundup
DJ
05:29pTech Down On Rotation Out Of Value Sectors -- Tech Roundup
DJ
05:25pFinancials Down As Volatility Washes Through Global Markets -- Financials Roundup
DJ
05:22pConsumer Cos Down As Traders Hedge On Rate Implications -- Consumer Roundup
DJ
Latest news "Economy & Forex"